Overview of the Pharma 4.0 Market The Pharma 4.0 market is at the forefront of transforming the pharmaceutical and biopharmaceutical sectors, emphasizing automation, digitization, and
Read MoreThe Global Point-of-care (POC) Diagnostics was valued at USD 50.09 billion in 2023 and is projected to reach approximately USD 120.35 billion by 2033, growing
Read More